Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

COST-EFFECTIVENESS ANALYSIS OF DIAGNOSTIC TESTS FOR DEVELOPMENT AND ADOPTION.

This one day course aims to explain how cost-effectiveness analysis of diagnostic tests is conducted and used in the research, development and evaluation of diagnostics. It is aimed at those involved in the development and evaluation of diagnostics, in both academic and commercial settings.

Prerequisites

Participants should have a basic understanding of measures of diagnostic accuracy and clinical effectiveness, as well as basic descriptive statistics (means, ranges). Previous knowledge of cost-effectiveness concepts would be an advantage, but these are not necessary as they will be revised in the first session. For the practical session, participants will need a laptop with Microsoft Excel installed.

By taking this course

Participants will revise the core concepts underlying cost-effectiveness analysis, including incremental cost-effectiveness ratios. They will learn how diagnostic tests can be evaluated using cost-effectiveness methods, and will get practical experience of working with a pre-built decision model and performing sensitivity analysis to understand how cost-effective a diagnostic would be in different settings. They will also learn about the diagnostic evaluation evidence requirements used by NICE, and consider contemporary issues related to cost-effectiveness analysis of diagnostics.

Course content (subject to minor changes)

1.  Introduction to cost-effectiveness for diagnostics

2.  Generating and using cost-effectiveness evidence for diagnostics

3.  Practical: Identifying evidence, decision modelling, and evaluating determinants of cost-effectiveness

4.  Evidence for implementation in routine clinical practice – NICE evaluations

5.  Evidencing the 'value' in value-based healthcare

Latest news

Major international trial shows rapid diagnostic tests need broader implementation support to reduce antibiotic prescribing

The PRUDENCE trial finds that rapid testing has clear value in specific clinical scenarios – but must be accompanied by training and communication strategies to change prescribing behaviour. Published in The Lancet Primary Care.

Theme lead recognised for pioneering ambulatory care work

Professor Dan Lasserson, co-lead of our Care Homes and Care in the Home theme, featured in the BMJ for his pioneering hospital-at-home work using point-of-care diagnostics.

Protocol published for pioneering UTI diagnostics study as first phase nears completion

Oxford's NIHR HealthTech Research Centre details the TOUCAN platform study for evaluating UTI diagnostic tests in primary care. This new approach allows multiple rapid tests to be assessed simultaneously, potentially accelerating their path to clinical use.